Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Cash from Operations (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Cash from Operations data on record, last reported at 1735000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 513.07% year-over-year to 1735000.0; the TTM value through Oct 2025 reached 6223000.0, up 329.89%, while the annual FY2025 figure was 7386000.0, 220.35% up from the prior year.
  • Cash from Operations reached 1735000.0 in Q4 2025 per CSBR's latest filing, down from 600000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6868000.0 in Q2 2025 and bottomed at 3991000.0 in Q3 2023.
  • Average Cash from Operations over 5 years is 436900.0, with a median of 263500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: soared 3053.33% in 2022, then crashed 1946.67% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 1228000.0 in 2021, then skyrocketed by 167.59% to 3286000.0 in 2022, then crashed by 82.08% to 589000.0 in 2023, then plummeted by 148.05% to 283000.0 in 2024, then plummeted by 513.07% to 1735000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 1735000.0 in Q4 2025, 600000.0 in Q3 2025, and 6868000.0 in Q2 2025.